Thomas Henkel
Directeur Général chez IMD Natural Solutions GmbH
Profil
Thomas Henkel is the founder of InterMed Discovery GmbH, founded in 2006, where he held the title of Managing Director from 2011 to 2012, and TARGOS Molecular Pathology GmbH, founded in 2005, where he previously held the title of Chief Executive Officer.
He is currently the Co-Managing Director at S Direkt-Marketing GmbH & Co. KG and IMD Natural Solutions GmbH.
Previously, he held the position of Vice President at Bayer AG and the title of Principal at Bayer HealthCare AG from 2003 to 2005.
He received his doctorate degree from the University of Gottingen in 1990.
Postes actifs de Thomas Henkel
| Sociétés | Poste | Début |
|---|---|---|
IMD Natural Solutions GmbH
 IMD Natural Solutions GmbH Food RetailRetail Trade IMD Natural Solutions GmbH develops preservative agents. Its product, INS Glycolipid, is a natural mushroom extract that is water soluble and can be used for preservation applications. The company was founded in 2012 and is headquartered in Dortmund, Germany. | Directeur Général | - |
S Direkt-Marketing GmbH & Co. KG
 S Direkt-Marketing GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Saalesparkasse, S Direkt-Marketing GmbH & Co. KG is a German company that specializes in telephone campaigns for product sales and efficient outbound campaigns for savings banks. The company is based in Halle, Germany. The company also design new platform offers and provide IT infrastructure, design interfaces to cooperation partners and content, and make fintech applications usable for savings banks. The CEOs of the company are Thomas Henkel, Ingo van Uehm. S Direkt-Marketing offers holistic solutions from a single source for savings banks and network partners, including media customer services, innovative added value, and new digital services. The company offers attractive positions for modern challenges. | Directeur Général | - |
TARGOS Molecular Pathology GmbH
 TARGOS Molecular Pathology GmbH BiotechnologyHealth Technology Part of Discovery Life Sciences LLC, TARGOS Molecular Pathology GmbH is a German company that provides biomarker services. The company is based in Kassel, Germany. The company was founded in 2005 by Reinhard Büttner, Josef Rüschoff, Thomas Henkel. Thomas Henkel has been the CEO since 2005. TARGOS Molecular Pathology was acquired by Discovery Life Sciences LLC on May 18, 2021. | Directeur Général | 01/01/2005 |
Anciens postes connus de Thomas Henkel
| Sociétés | Poste | Fin |
|---|---|---|
InterMed Discovery GmbH
 InterMed Discovery GmbH Miscellaneous Commercial ServicesCommercial Services InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales. | Fondateur | 21/08/2012 |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Corporate Officer/Principal | 01/01/2005 |
| BAYER AG | Corporate Officer/Principal | - |
Formation de Thomas Henkel
| University of Gottingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BAYER AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
InterMed Discovery GmbH
InterMed Discovery GmbH Miscellaneous Commercial ServicesCommercial Services InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales. | Commercial Services |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
IMD Natural Solutions GmbH
IMD Natural Solutions GmbH Food RetailRetail Trade IMD Natural Solutions GmbH develops preservative agents. Its product, INS Glycolipid, is a natural mushroom extract that is water soluble and can be used for preservation applications. The company was founded in 2012 and is headquartered in Dortmund, Germany. | Retail Trade |
S Direkt-Marketing GmbH & Co. KG
S Direkt-Marketing GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Saalesparkasse, S Direkt-Marketing GmbH & Co. KG is a German company that specializes in telephone campaigns for product sales and efficient outbound campaigns for savings banks. The company is based in Halle, Germany. The company also design new platform offers and provide IT infrastructure, design interfaces to cooperation partners and content, and make fintech applications usable for savings banks. The CEOs of the company are Thomas Henkel, Ingo van Uehm. S Direkt-Marketing offers holistic solutions from a single source for savings banks and network partners, including media customer services, innovative added value, and new digital services. The company offers attractive positions for modern challenges. | Commercial Services |
TARGOS Molecular Pathology GmbH
TARGOS Molecular Pathology GmbH BiotechnologyHealth Technology Part of Discovery Life Sciences LLC, TARGOS Molecular Pathology GmbH is a German company that provides biomarker services. The company is based in Kassel, Germany. The company was founded in 2005 by Reinhard Büttner, Josef Rüschoff, Thomas Henkel. Thomas Henkel has been the CEO since 2005. TARGOS Molecular Pathology was acquired by Discovery Life Sciences LLC on May 18, 2021. | Health Technology |
